Articles Published in 2012

Ambit completes $25M financing for AML drug

Wednesday, November 7, 2012 10:36 AM

Ambit Biosciences, a privately held biopharmaceutical company based in San Diego, has closed the first $25 million tranche of a new $50 million preferred stock financing to support continued advancement of its lead drug candidate, quizartinib, for the treatment of acute myeloid leukemia (AML).

More... »

Icon launches new FSP strategy

Wednesday, November 7, 2012 10:03 AM

Global CRO Icon has launched a new functional resourcing strategy delivered by a dedicated division, DOCS, consolidating functional service provision (FSP) and resourcing services into one division.

More... »

BioNano Genomics launches Irys for complex human genome analysis

Wednesday, November 7, 2012 09:47 AM

BioNano Genomics, a San Diego-based genomics company, has launched its Irys System, an intuitively designed genome mapping system that empowers genomics researchers with a new way of analyzing genomic DNA.

More... »

Greenphire chosen for long-term global trial

Wednesday, November 7, 2012 09:17 AM

King of Prussia, Penn.-based Greenphire, a provider of payment technologies for the clinical trials industry, said its ClinCard Technology Platform has been chosen for use in a large, phase III clinical trial to include more than 1,000 patients across six countries. The trial is expected to last more than five years. 

More... »

Curie-Cancer, Harmonic to explore anti-cancer activity of several compounds

Monday, November 5, 2012 03:21 PM

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and Harmonic Pharma, a French company focused on extending the therapeutic application of compounds already on the market, have entered into a research collaboration aimed at exploring the anti-cancer activity of several molecules in Harmonic’s portfolio.

More... »

CRA, Radiant Research form largest, most therapeutically diverse SMO in U.S.

Monday, November 5, 2012 01:15 PM

CRA Holdings has acquired Radiant Research, a comprehensive research company based in Cincinnati. Clinical Research Advantage (CRA), a provider of research services also owned by CRA Holdings, will be combined with Radiant Research, creating an organization with 57 sites with more than 550 research professionals and an aggressive plan for growth.

More... »

SAFC to support next-gen NSAID product development

Monday, November 5, 2012 11:16 AM

Sigma-Aldrich’s custom manufacturing and services business unit, SAFC, has signed an agreement with South Korea-based CrystalGenomics, a clinical stage biopharmaceutical company, to support the development of active pharmaceutical ingredients (APIs) for next-generation non-steroidal anti-inflammatory drugs (NSAID).

More... »

Ziarco founded with Series A financing

Monday, November 5, 2012 11:01 AM

Recently founded Ziarco, a clinical-stage biotech focused on therapeutics targeting inflammatory and allergic diseases, has closed an initial $6 million tranche of Series A financing totaling $27 million. The round was led by Biotechnology Value Fund, with participation by Pfizer Venture Investments.

More... »

Pacific BioLabs acquires Bay Bioanalytical Laboratory

Monday, November 5, 2012 10:22 AM

Pacific BioLabs (PBL), a biological testing service based in Hercules, Calif., has acquired Bay Bioanalytical Laboratory (BBL), a contract laboratory also based in Hercules, adding analytical and bioanalytical chemistry to PBL's existing in vivo preclinical and microbiological testing services.

More... »

Icon reports Q3 revenue of $286M

Monday, November 5, 2012 09:24 AM

Icon, a global provider of outsourced development services, reported its financial results for the third quarter ended September 30, 2012. Net revenues for the quarter grew 19% to $286 million compared to $241 million in the same quarter last year.

More... »